MetLife Investment Management’s MaxLinear MXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $784K | Sell |
45,059
-382
| -0.8% | -$6.86K | ﹤0.01% | 1518 |
|
|
2025
Q4 | $792K | Sell |
45,441
-2,471
| -5% | -$40.2K | ﹤0.01% | 1560 |
|
|
2025
Q3 | $770K | Hold |
47,912
| – | – | ﹤0.01% | 1599 |
|
|
2025
Q2 | $681K | Buy |
47,912
+234
| +0.5% | +$2.7K | ﹤0.01% | 1524 |
|
|
2025
Q1 | $518K | Sell |
47,678
-914
| -2% | -$15.3K | ﹤0.01% | 1710 |
|
|
2024
Q4 | $961K | Buy |
48,592
+3,314
| +7% | +$53.2K | 0.01% | 1434 |
|
|
2024
Q3 | $656K | Hold |
45,278
| – | – | ﹤0.01% | 1631 |
|
|
2024
Q2 | $912K | Buy |
45,278
+5,887
| +15% | +$116K | 0.01% | 1387 |
|
|
2024
Q1 | $735K | Hold |
39,391
| – | – | ﹤0.01% | 1470 |
|
|
2023
Q4 | $936K | Buy |
39,391
+990
| +3% | +$19.4K | 0.01% | 1331 |
|
|
2023
Q3 | $854K | Hold |
38,401
| – | – | 0.01% | 1319 |
|
|
2023
Q2 | $1.21M | Hold |
38,401
| – | – | 0.01% | 1158 |
|
|
2023
Q1 | $1.35M | Buy |
38,401
+625
| +2% | +$22.6K | 0.01% | 1075 |
|
|
2022
Q4 | $1.28M | Hold |
37,776
| – | – | 0.01% | 1091 |
|
|
2022
Q3 | $1.23M | Hold |
37,776
| – | – | 0.01% | 1084 |
|
|
2022
Q2 | $1.28M | Hold |
37,776
| – | – | 0.01% | 1089 |
|
|
2022
Q1 | $2.2M | Buy |
37,776
+13,398
| +55% | +$816K | 0.01% | 953 |
|
|
2021
Q4 | $1.84M | Hold |
24,378
| – | – | 0.02% | 896 |
|
|
2021
Q3 | $1.2M | Sell |
24,378
-1,569
| -6% | -$75.9K | 0.01% | 1042 |
|
|
2021
Q2 | $1.1M | Hold |
25,947
| – | – | 0.01% | 1109 |
|
|
2021
Q1 | $884K | Sell |
25,947
-3,218
| -11% | -$115K | 0.01% | 1215 |
|
|
2020
Q4 | $1.11M | Hold |
29,165
| – | – | 0.01% | 1078 |
|
|
2020
Q3 | $678K | Hold |
29,165
| – | – | 0.01% | 1223 |
|
|
2020
Q2 | $626K | Hold |
29,165
| – | – | 0.01% | 1255 |
|
|
2020
Q1 | $340K | Hold |
29,165
| – | – | ﹤0.01% | 1423 |
|
|
2019
Q4 | $619K | Hold |
29,165
| – | – | 0.01% | 1337 |
|
|
2019
Q3 | $653K | Hold |
29,165
| – | – | 0.01% | 1281 |
|
|
2019
Q2 | $684K | Buy |
29,165
+2,466
| +9% | +$60.1K | 0.01% | 1301 |
|
|
2019
Q1 | $682K | Hold |
26,699
| – | – | 0.01% | 1271 |
|
|
2018
Q4 | $470K | Hold |
26,699
| – | – | 0.01% | 1403 |
|
|
2018
Q3 | $531K | Hold |
26,699
| – | – | 0.01% | 1500 |
|
|
2018
Q2 | $416K | Hold |
26,699
| – | – | ﹤0.01% | 1519 |
|
|
2018
Q1 | $607K | Hold |
26,699
| – | – | 0.01% | 1256 |
|
|
2017
Q4 | $705K | Buy |
+26,699
| New | +$667K | 0.01% | 1200 |
|
Other funds holding MXL
VPM
VCM
MetLife Investment Management's MXL Position: Q1 2026 in Review
MetLife Investment Management reduced its MaxLinear (MXL) stake by 0.84% in Q1 2026, selling an estimated $6.86K and leaving 45,059 shares worth $784K. The position accounts for ﹤0.01% of the portfolio, ranked #1518.
MetLife Investment Management first reported a position in MXL in Q4 2017 and has held it in 34 quarters since. The position peaked at $2.2M in Q1 2022. 238 funds tracked by Wall St. Rank hold MXL as of Q1 2026.
- MetLife Investment Management held 45,059 shares of MaxLinear worth $784K as of Q1 2026.
- MetLife Investment Management sold 382 MaxLinear shares in Q1 2026, an estimated $6.86K.
- MaxLinear made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1518 holding.
- MetLife Investment Management first reported a position in MaxLinear in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's MaxLinear position peaked at $2.2M in Q1 2022.
- 238 funds tracked by Wall St. Rank held MaxLinear as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.